論文・総説 - 壽美田　一貴

41. Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nature cell biology. 2019.08; 21 (8): 1003-1014. ( PubMed, DOI )

42. Jun Karakama, Tadashi Nariai, Shoko Hara, Shihori Hayashi, Kazutaka Sumita, Motoki Inaji, Yoji Tanaka, Kei Wagatsuma, Kenji Ishii, Shigeru Nemoto, Taketoshi Maehara. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status. J Stroke Cerebrovasc Dis. 2018.08; 27 (8): 2147-2157. ( PubMed, DOI )

43. Hiroyuki Akagawa, Maki Mukawa, Tadashi Nariai, Shunsuke Nomura, Yasuo Aihara, Hideaki Onda, Taku Yoneyama, Takumi Kudo, Kazutaka Sumita, Taketoshi Maehara, Takakazu Kawamata, Hidetoshi Kasuya. variants in Japanese pediatric patients with moyamoya disease. Hum Genome Var. 2018.01; 5 17060. ( PubMed, DOI )

44. Xiaoshu Dong, Kaoru Tamura, Daisuke Kobayashi, Noboru Ando, Kazutaka Sumita, Taketoshi Maehara. LAPTM4B-35 is a novel prognostic factor for glioblastoma. J. Neurooncol.. 2017.04; 132 (2): 295-303. ( PubMed, DOI )

45. Maki Mukawa, Tadashi Nariai, Hideaki Onda, Taku Yoneyama, Yasuo Aihara, Kengo Hirota, Takumi Kudo, Kazutaka Sumita, Taketoshi Maehara, Takakazu Kawamata, Hidetoshi Kasuya, Hiroyuki Akagawa. Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease. J Stroke Cerebrovasc Dis. 2016.10; 26 (1): 150-161. ( PubMed, DOI )

46. Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016.08; 4 (1): 79. ( PubMed, DOI )

47. Kazutaka Sumita, Yu-Hua Lo, Koh Takeuchi, Miki Senda, Satoshi Kofuji, Yoshiki Ikeda, Jumpei Terakawa, Mika Sasaki, Hirofumi Yoshino, Nazanin Majd, Yuxiang Zheng, Emily Rose Kahoud, Takehiro Yokota, Brooke M Emerling, John M Asara, Tetsuo Ishida, Jason W Locasale, Takiko Daikoku, Dimitrios Anastasiou, Toshiya Senda, Atsuo T Sasaki. The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis. Mol. Cell. 2016.01; 61 (2): 187-198. ( PubMed, DOI )

48. Miho Watanabe, Haiying Li, Aimee G Kim, Aaron Weilerstein, Anteneta Radu, Marcus Davey, Stavros Loukogeorgakis, Melissa D Sánchez, Kazutaka Sumita, Naoki Morimoto, Masaya Yamamoto, Yasuhiko Tabata, Alan W Flake. Complete tissue coverage achieved by scaffold-based tissue engineering in the fetal sheep model of Myelomeningocele. Biomaterials. 2016.01; 76 133-143. ( PubMed, DOI )

49. Nazanin Majd, Kazutaka Sumita, Hirofumi Yoshino, Dillon Chen, Jumpei Terakawa, Takiko Daikoku, Satoshi Kofuji, Richard Curry, Trisha M. Wise-Draper, Ronald E. Warnick, Jessica Guarnascheli, Atsuo T. Sasaki. A review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic, Journal of Cancer Resarch Journal of Cancer Resarch. 2014.07;

50. Kazutaka Sumita, Hirofumi Yoshino, Mika Sasaki, Nazanin Majd, Emily Rose Kahoud, Hidenori Takahashi, Koh Takeuchi, Taruho Kuroda, Susan Lee, Pascale G Charest, Kosuke Takeda, John M Asara, Richard A Firtel, Dimitrios Anastasiou, Atsuo T Sasaki. Degradation of activated K-Ras orthologue via K-Ras-specific lysine residues is required for cytokinesis. J. Biol. Chem.. 2014.02; 289 (7): 3950-3959. ( PubMed, DOI )

51. Rachael Baker, Emily M Wilkerson, Kazutaka Sumita, Daniel G Isom, Atsuo T Sasaki, Henrik G Dohlman, Sharon L Campbell. Differences in the regulation of K-Ras and H-Ras isoforms by monoubiquitination. J. Biol. Chem.. 2013.12; 288 (52): 36856-36862. ( PubMed, DOI )

52. Arasukumar Subramani, Samer Alsidawi, Sajjeev Jagannathan, Kazutaka Sumita, Atsuo T Sasaki, Bruce Aronow, Ronald E Warnick, Sean Lawler, James J Driscoll. The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis. Sci Rep. 2013.08; 3 2392. ( PubMed, DOI )

53. Mindy I Davis, Atsuo T Sasaki, Min Shen, Brooke M Emerling, Natasha Thorne, Sam Michael, Rajan Pragani, Matthew Boxer, Kazutaka Sumita, Koh Takeuchi, Douglas S Auld, Zhuyin Li, Lewis C Cantley, Anton Simeonov. A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation. PLoS ONE. 2013.01; 8 (1): e54127. ( PubMed, DOI )

54. Yijun Bao, Kazutaka Sumita, Takumi Kudo, Kanchanamala Withanage, Kentaro Nakagawa, Mitsunobu Ikeda, Kikuo Ohno, Yunjie Wang, Yutaka Hata. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases. Genes Cells. 2009.12; 14 (12): 1369-1381. ( PubMed, DOI )

55. S Hirabayashi, K Nakagawa, K Sumita, S Hidaka, T Kawai, M Ikeda, A Kawata, K Ohno, Y Hata. Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1. Oncogene. 2008.07; 27 (31): 4281-4292. ( PubMed, DOI )

56. Junko Iida, Hiroyoshi Ishizaki, Miki Okamoto-Tanaka, Akira Kawata, Kazutaka Sumita, Shintaro Ohgake, Yuji Sato, Hiroshi Yorifuji, Nobuyuki Nukina, Kazumasa Ohashi, Kensaku Mizuno, Tomonari Tsutsumi, Akira Mizoguchi, Jun Miyoshi, Yoshimi Takai, Yutaka Hata. Synaptic scaffolding molecule alpha is a scaffold to mediate N-methyl-D-aspartate receptor-dependent RhoA activation in dendrites. Mol. Cell. Biol.. 2007.06; 27 (12): 4388-4405. ( PubMed, DOI )

57. Kazutaka Sumita, Yuji Sato, Junko Iida, Akira Kawata, Mamiko Hamano, Susumu Hirabayashi, Kikuo Ohno, Elior Peles, Yutaka Hata. Synaptic scaffolding molecule (S-SCAM) membrane-associated guanylate kinase with inverted organization (MAGI)-2 is associated with cell adhesion molecules at inhibitory synapses in rat hippocampal neurons. J. Neurochem.. 2007.01; 100 (1): 154-166. ( PubMed, DOI )

58. Akira Kawata, Junko Iida, Mitsunobu Ikeda, Yuji Sato, Hiroki Mori, Ai Kansaku, Kazutaka Sumita, Naoyuki Fujiwara, Chiaki Rokukawa, Mamiko Hamano, Susumu Hirabayashi, Yutaka Hata. CIN85 is localized at synapses and forms a complex with S-SCAM via dendrin. J. Biochem.. 2006.05; 139 (5): 931-939. ( PubMed, DOI )

59. 壽美田 一貴, 藤井 照子, 藤田 恭平. 【血栓回収療法リニューアル　適応・画像診断・デバイスの新常識】第3章　都心部と地域での医療体制の違い　都心部での体制 脳神経外科速報. 2022.10; (2022増刊): 88-94. ( 医中誌 )

60. Kim Y, Kudo T, Tamura K, Sumita K, Kobayashi D, Tanaka Y, Inaji M, Nariai T, Ishii K, Maehara T. [Clinical Findings of Thalamic and Brainstem Glioma Including Diffuse Midline Glioma, H3K27M Mutant:A Clinical Study]. No shinkei geka. Neurological surgery. 2021.07; 49 (4): 901-908. ( PubMed, DOI )